Genital Diseases, Female  >>  seribantumab (MM-121)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
seribantumab (MM-121) / Elevation Oncology
NCT01447706: A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers

Checkmark PFS data in biomarker selected population including breast cancer, ovarian cancer, and lung cancer
May 2015 - May 2015: PFS data in biomarker selected population including breast cancer, ovarian cancer, and lung cancer
Checkmark MM-121 + paclitaxel combo trial for ovarian cancer
Jun 2014 - Jun 2014: MM-121 + paclitaxel combo trial for ovarian cancer
Checkmark In combination with paclitaxel in pts with platinum-resistant/refractory adv ovarian cancers
More
Completed
2
223
US
MM-121, SAR256212, Paclitaxel
Merrimack Pharmaceuticals, Sanofi
Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer
09/13
06/15

Download Options